DiaSorin (OTCMKTS:DSRLF) Sees Unusually-High Trading Volume – Here’s What Happened

Shares of DiaSorin S.p.A. (OTCMKTS:DSRLF) saw unusually-strong trading volume on Wednesday . Approximately 1,000 shares traded hands during mid-day trading, an increase of 179% from the previous session’s volume of 359 shares.The stock last traded at $81.00 and had previously closed at $80.00.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on DSRLF shares. BNP Paribas Exane cut shares of DiaSorin from a “neutral” rating to an “underperform” rating in a report on Tuesday, July 7th. Piper Sandler initiated coverage on DiaSorin in a research note on Thursday, June 11th. They set a “neutral” rating for the company. Deutsche Bank Aktiengesellschaft downgraded DiaSorin from a “hold” rating to a “sell” rating in a report on Wednesday, June 17th. Zacks Research upgraded DiaSorin to a “hold” rating in a report on Tuesday, May 12th. Finally, UBS Group cut shares of DiaSorin from a “buy” rating to a “neutral” rating in a research note on Thursday, April 9th. Two investment analysts have rated the stock with a Buy rating, three have given a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Hold”.

DiaSorin Stock Performance

The firm has a 50-day moving average of $78.37 and a 200 day moving average of $76.61.

DiaSorin Company Profile

DiaSorin S.p.A. is an Italy‐based global biotechnology company specializing in the development, manufacture and marketing of in vitro diagnostic products. Headquartered in Saluggia, DiaSorin serves clinical laboratories, hospitals and physician offices with a broad portfolio of immunodiagnostic assays and molecular diagnostic tests. The company’s shares trade on the Milan Stock Exchange and are available in the United States as over‐the‐counter (OTC) securities under the symbol DSRLF.

At the core of DiaSorin’s business are immunodiagnostic systems that measure antibodies, antigens and hormones in human samples.